scholarly journals Antiretroviral Treatment Interruptions Among Black and Latina Transgender Women Living with HIV: Characterizing Co-occurring, Multilevel Factors Using the Gender Affirmation Framework

2019 ◽  
Vol 23 (9) ◽  
pp. 2588-2599 ◽  
Author(s):  
Joseph G. Rosen ◽  
Mannat Malik ◽  
Erin E. Cooney ◽  
Andrea L. Wirtz ◽  
Thespina Yamanis ◽  
...  
Keyword(s):  
Antiretroviral Treatment ◽  
Transgender Women ◽  
Women Living With Hiv ◽  
Treatment Interruptions ◽  
Gender Affirmation ◽  
Living With Hiv

Adherence to antiretroviral treatment and quality of life among transgender women living with HIV/AIDS in São Paulo, Brazil

AIDS Care ◽  
2020 ◽  
Vol 33 (1) ◽  
pp. 31-38 ◽  
Author(s):  
Thiago E. Sabino ◽  
Vivian I. Avelino-Silva ◽  
Clara Cavalcantte ◽  
Silvia P. Goulart ◽  
Olinda C. Luiz ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Antiretroviral Treatment ◽  
Sao Paulo ◽  
Transgender Women ◽  
São Paulo ◽  
Women Living With Hiv ◽  
Living With Hiv ◽  
Hiv Aids

scholarly journals Feasibility of SMS to remind pregnant and breastfeeding women living with HIV to take antiretroviral treatment in Kilimanjaro region, Tanzania: a pilot study

2020 ◽  
Vol 4 (2) ◽  
pp. 140-148
Author(s):  
Kennedy M Ngowi ◽  
Eusebious Maro ◽  
Rob E Aarnoutse ◽  
Blandina T Mmbaga ◽  
Mirjam A. G Sprangers ◽  
...  
Keyword(s):  
Pilot Study ◽  
Antiretroviral Treatment ◽  
Network Failure ◽  
Women Living With Hiv ◽  
Resource Limited ◽  
Sms Reminders ◽  
Kilimanjaro Christian Medical Centre ◽  
Living With Hiv ◽  
Lost To Follow Up ◽  
Privacy Issues

Background: Pregnant and breastfeeding Women Living with HIV (WLHIV) often have difficulties in reaching adequate levels of adherence (>95%) to Antiretroviral treatment. “Forgetting” is the most commonly mentioned reason. Sending reminders via SMS is expected to improve adherence. We conducted a pilot study to investigate acceptability, user experience and technical feasibility of sending reminder-SMS to WLHIV. Methods: This was a 6-months observational pilot-study among WLHIV attending antenatal and postnatal care at Kilimanjaro Christian Medical Centre in Moshi, Tanzania. Women received a reminder-SMS 30 minutes before usual time of intake. One hour later, they received an SMS asking whether they took medication to which they could reply with ‘Yes’ or ‘No’. Messages were sent 3 times a week on randomly chosen days to prevent reliance on daily messages. We calculated the percentage of number of SMS delivered, failed to be delivered, and replied to. We analysed feedback from exit-interviews about experience with the SMS-reminders. Results: 25 women were enrolled (age 18-45), 2 were lost to follow up. 5,054 messages were sent of which 53 failed to be delivered (1%). 1,880 SMS were sent with a question if medication was taken; 1,012 (54%) messages were replied to, of which 1,003 (99%) were replied with ‘YES’ and closely to ‘YES’, and a total of 9 (1%) with ‘NO’ and ‘closely to NO’. 868 messages (46%) were not responded to due to either dropout, change of phone number, loss of phone or network failure. Results from 18 interviews showed that 16 (89%) women were satisfied with SMS reminders. 2 (11%) were concerned about unwanted disclosure because of the content ‘don’t forget to take medication’ and one reported other privacy issues (6%). 3 (17%) women experienced stigma. Conclusion: 99%of SMS being delivered indicates that SMS reminders in this resource-limited setting are technically feasible. However, concerns regarding privacy were noted, specifically the risk of unwanted disclosure and the experience of stigma. Participants indicated that being made aware of their adherence, motivated them to adhere better. However, personalised and more neutral content of the SMS might be a way to improving the intervention.

A qualitative study of resilience among transgender women living with HIV in response to stigma in healthcare

AIDS Care ◽  
2020 ◽  
Vol 32 (8) ◽  
pp. 1008-1013
Author(s):  
Ashley Lacombe-Duncan ◽  
Carmen H. Logie ◽  
Peter A. Newman ◽  
Greta R. Bauer ◽  
Mina Kazemi
Keyword(s):  
Qualitative Study ◽  
Transgender Women ◽  
Women Living With Hiv ◽  
Living With Hiv

scholarly journals Integration of Gender-Affirming Primary Care and Peer Navigation With HIV Prevention and Treatment Services to Improve the Health of Transgender Women: Protocol for a Prospective Longitudinal Cohort Study (Preprint)

2019 ◽  
Author(s):  
Javier R Lama ◽  
Kenneth H Mayer ◽  
Amaya G Perez-Brumer ◽  
Leyla Huerta ◽  
Hugo Sanchez ◽  
...  
Keyword(s):  
Primary Care ◽  
Cohort Study ◽  
Hiv Prevention ◽  
Hormone Therapy ◽  
Transgender Women ◽  
Treatment Services ◽  
Prevention And Treatment ◽  
Gender Affirmation ◽  
Peer Navigation ◽  
Living With Hiv

BACKGROUND Public health strategies are urgently needed to improve HIV disparities among transgender women, including holistic intervention approaches that address those health needs prioritized by the community. Hormone therapy is the primary method by which many transgender women medically achieve gender affirmation. Peer navigation has been shown to be effective to engage and retain underserved populations living with HIV in stable primary medical care. OBJECTIVE This study aims to assess the feasibility and acceptability of an integrated innovative HIV service delivery model designed to improve HIV prevention and care by combining gender-affirming primary care and peer navigation with HIV prevention and treatment services. METHODS A 12-month, nonrandomized, single-arm cohort study was implemented in Lima, Peru, among adult individuals, assigned a male sex at birth, who identified themselves as transgender women, regardless of initiation or completion of medical gender affirmation, and who were unaware of their HIV serostatus or were living with HIV but not engaged in HIV treatment. HIV-negative participants received quarterly HIV testing and were offered to initiate pre-exposure prophylaxis. HIV-positive participants were offered to initiate antiretroviral treatment and underwent quarterly plasma HIV-1 RNA and peripheral CD4+ lymphocyte cell count monitoring. All participants received feminizing hormone therapy and adherence counseling and education on their use. Peer health navigation facilitated retention in care by visiting participants at home, work, or socialization venues, or by contacting them by social media and phone. RESULTS Patient recruitment started in October 2016 and finished in March 2017. The cohort ended follow-up on March 2018. Data analysis is currently underway. CONCLUSIONS Innovative and culturally sensitive strategies to improve access to HIV prevention and treatment services for transgender women are vital to curb the burden of HIV epidemic for this key population. Findings of this intervention will inform future policies and research, including evaluation of its efficacy in a randomized controlled trial. CLINICALTRIAL ClinicalTrials.gov NCT03757117; https://clinicaltrials.gov/ct2/show/NCT03757117 INTERNATIONAL REGISTERED REPOR DERR1-10.2196/14091

scholarly journals Intensification of antiretroviral treatment with raltegravir for pregnant women living with HIV at high risk of vertical transmission

2018 ◽  
Vol 4 (2) ◽  
pp. 61-65 ◽  
Author(s):  
Thanyawee Puthanakit ◽  
Nattawan Thepnarong ◽  
Surasith Chaithongwongwatthana ◽  
Suvaporn Anugulruengkitt ◽  
Orawan Anunsittichai ◽  
...  
Keyword(s):  
High Risk ◽  
Pregnant Women ◽  
Vertical Transmission ◽  
Antiretroviral Treatment ◽  
Women Living With Hiv ◽  
Living With Hiv
Sign in / Sign up

Export Citation Format

Share Document